|
Insider Trading: Endo Pharmaceuticals Holdings Inc
Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Endo Pharmaceuticals Holdings Inc in the last 24 months are illustrated in figures 1 and 2. Table 1 shows the monthly insider trading data of Endo Pharmaceuticals Holdings Inc since year 2005. Table 2 shows the detailed insider transactions of Endo Pharmaceuticals Holdings Inc since 2005.
The reporting company's ticker symbol is ENDP.
The reporting company's CIK number is 1100962.
The total value of stock buying since 2005 is $49,492.
The total value of stock sales is $6,968,932,791.
The total value of stock exercises is $8,316,739.
1 year stock price chart,
1 day stock price chart
opopp opopopop
Figure 1. Monthly insider transaction values at Endo Pharmaceuticals Holdings Inc (ENDP) in the past 24 months.
The trade values of insider stock buys, sales, and option exercises are in logarithmic scale
as shown on the right axis labels.
The detailed monthly and daily insider transactions are listed in the 2 tables below.
09 10 11 12 01 2007 02 03 04 05 06 07 08 09 10 11 12 01 2008 02 03 04 05 06 07 08 -
Figure 2. Average prices of insider buys, sales, and option exercises at Endo Pharmaceuticals Holdings Inc (ENDP) in the past 24 months. See table 2 for insider transaction details.
09 10 11 12 01 2007 02 03 04 05 06 07 08 09 10 11 12 01 2008 02 03 04 05 06 07 08 -
Table 1. Monthly summaries of insider stock purchases, sales, and option exercises
for Endo Pharmaceuticals Holdings Inc (ENDP).
Trading Period
year-month |
Insider Buying
Shares Value ($) |
Insider Sales
Shares Value ($) |
Option Exercises
Shares Value ($) |
| 2008-08 | 2,150 | 49,492 | 400 | 9,368 | 0 | 0 |
| 2007-07 | 0 | 0 | 59,660 | 2,082,134 | 59,660 | 553,943 |
| 2006-12 | 0 | 0 | 43,652 | 1,200,665 | 43,652 | 400,288 |
| 2006-11 | 0 | 0 | 853,545 | 21,979,184 | 43,652 | 400,288 |
| 2006-10 | 0 | 0 | 43,652 | 1,300,899 | 43,652 | 400,288 |
| 2006-09 | 0 | 0 | 43,652 | 1,434,801 | 43,652 | 400,288 |
| 2006-08 | 0 | 0 | 43,652 | 1,368,843 | 43,652 | 400,288 |
| 2006-07 | 0 | 0 | 43,652 | 1,322,022 | 43,652 | 400,288 |
| 2006-06 | 0 | 0 | 43,652 | 1,291,946 | 43,652 | 0 |
| 2006-05 | 0 | 0 | 43,652 | 1,412,962 | 43,652 | 316,477 |
| 2006-04 | 0 | 0 | 43,652 | 1,377,871 | 43,652 | 316,477 |
| 2006-03 | 0 | 0 | 1,855,550 | 58,740,548 | 1,552,146 | 4,217,568 |
| 2006-01 | 0 | 0 | 97,455,878 | 2,682,102,807 | 40,009 | 510,546 |
| 2005-11 | 0 | 0 | 43,684 | 1,310,956 | 0 | 0 |
| 2005-10 | 0 | 0 | 160,983,018 | 4,191,997,785 | 0 | 0 |
Table 2. Detailed insider stock purchases, sales, and option exercises
for Endo Pharmaceuticals Holdings Inc (ENDP)
| Trade Date |
Insider Name |
Trade Type |
Shares |
Price ($) |
Value ($) |
| 2008-08-12 | Kimmel Roger H (Director) | Sale | 400 | 23.42 | 9,368 |
| 2008-08-04 | Scodari Joseph C (Director) | Purchase | 2,150 | 23.02 | 49,492 |
| 2007-07-03 | Manogue Caroline B (Exec. V.P., CLO & Secy) | Sale | 59,660 | 34.90 | 2,082,134 |
| 2007-07-03 | Manogue Caroline B (Exec. V.P., CLO & Secy) | Option Exercise | 59,660 | 9.28 | 553,943 |
| 2006-12-04 | Lankau Peter A (President & CEO) | Sale | 43,652 | 27.51 | 1,200,665 |
| 2006-12-04 | Lankau Peter A (President & CEO) | Option Exercise | 43,652 | 9.17 | 400,288 |
| 2006-11-29 | Ammon Carol A (Director) | Sale | 809,893 | 25.60 | 20,733,260 |
| 2006-11-01 | Lankau Peter A (President & CEO) | Sale | 43,652 | 28.54 | 1,245,924 |
| 2006-11-01 | Lankau Peter A (President & CEO) | Option Exercise | 43,652 | 9.17 | 400,288 |
| 2006-10-23 | Lankau Peter A (President & CEO) | Sale | 43,652 | 29.80 | 1,300,899 |
| 2006-10-23 | Lankau Peter A (President & CEO) | Option Exercise | 43,652 | 9.17 | 400,288 |
| 2006-09-01 | Lankau Peter A (President & CEO) | Sale | 43,652 | 32.87 | 1,434,801 |
| 2006-09-01 | Lankau Peter A (President & CEO) | Option Exercise | 43,652 | 9.17 | 400,288 |
| 2006-08-01 | Lankau Peter A (President & CEO) | Sale | 43,652 | 31.36 | 1,368,843 |
| 2006-08-01 | Lankau Peter A (President & CEO) | Option Exercise | 43,652 | 9.17 | 400,288 |
| 2006-07-24 | Lankau Peter A (President & CEO) | Sale | 43,652 | 30.29 | 1,322,022 |
| 2006-07-24 | Lankau Peter A (President & CEO) | Option Exercise | 43,652 | 9.17 | 400,288 |
| 2006-06-01 | Lankau Peter A (President & CEO) | Sale | 43,652 | 29.60 | 1,291,946 |
| 2006-06-01 | Lankau Peter A (President & CEO) | Option Exercise | 43,652 | .00 | 0 |
| 2006-05-01 | Lankau Peter A (President & CEO) | Sale | 43,652 | 32.37 | 1,412,962 |
| 2006-05-01 | Lankau Peter A (President & CEO) | Option Exercise | 43,652 | 7.25 | 316,477 |
| 2006-04-24 | Lankau Peter A (President & CEO) | Sale | 43,652 | 31.56 | 1,377,871 |
| 2006-04-24 | Lankau Peter A (President & CEO) | Option Exercise | 43,652 | 7.25 | 316,477 |
| 2006-03-27 | O Donnell Joseph T Jr (Director) | Sale | 15,000 | 31.65 | 474,750 |
| 2006-03-27 | O Donnell Joseph T Jr (Director) | Option Exercise | 15,000 | 8.94 | 134,062 |
| 2006-03-27 | Mitchell Michael W (Other) | Sale | 7,500 | 31.65 | 237,375 |
| 2006-03-27 | Mitchell Michael W (Other) | Option Exercise | 7,500 | 16.13 | 120,993 |
| 2006-03-27 | Lee David A H (Exec. V.P and CSO) | Sale | 468,686 | 31.65 | 14,833,911 |
| 2006-03-27 | Lee David A H (Exec. V.P and CSO) | Option Exercise | 235,282 | 2.42 | 569,382 |
| 2006-03-27 | Ammon Carol A (Director) | Sale | 1,246,962 | 31.65 | 39,466,347 |
| 2006-03-27 | Ammon Carol A (Director) | Option Exercise | 1,246,962 | 2.42 | 3,017,648 |
| 2006-03-27 | Kimmel Roger H (Director) | Sale | 70,000 | 31.65 | 2,215,500 |
| 2006-03-27 | Clingen Brian T (Other) | Sale | 3,750 | 31.65 | 118,687 |
| 2006-03-27 | Clingen Brian T (Other) | Option Exercise | 3,750 | 15.74 | 59,006 |
| 2006-03-01 | Lankau Peter A (President & CEO) | Sale | 43,652 | 31.93 | 1,393,978 |
| 2006-03-01 | Lankau Peter A (President & CEO) | Option Exercise | 43,652 | 7.25 | 316,477 |
| 2006-01-24 | Connors James J Ii (10% Owner) | Sale | 46,029,665 | 27.52 | 1,266,736,377 |
| 2006-01-24 | Mitchell Michael W (Director) | Sale | 18,750 | 27.52 | 516,000 |
| 2006-01-24 | Mitchell Michael W (Director) | Option Exercise | 18,750 | 12.34 | 231,300 |
| 2006-01-24 | Black Jeffrey R (Exec. V.P., CFO and) | Sale | 669,350 | 27.52 | 18,420,512 |
| 2006-01-24 | Manogue Caroline B (Exec. V.P., CLO & Se) | Sale | 41,966 | 27.52 | 1,154,904 |
| 2006-01-24 | Lee David A H (Exec. V.P and CSO) | Sale | 755,379 | 27.52 | 20,788,030 |
| 2006-01-24 | Lankau Peter A (President & CEO) | Sale | 33,048 | 27.52 | 909,480 |
| 2006-01-24 | Ammon Carol A (Director) | Sale | 2,033,228 | 27.52 | 55,954,434 |
| 2006-01-24 | Endo Pharma Llc (10% Owner) | Sale | 9,366,256 | 27.52 | 257,759,365 |
| 2006-01-24 | Hyatt Michael (Director) | Sale | 200,000 | 27.52 | 5,504,000 |
| 2006-01-24 | Kimmel Roger H (Director) | Sale | 164,306 | 27.52 | 4,521,701 |
| 2006-01-24 | Kimmel Roger H (Director) | Option Exercise | 16,259 | 12.34 | 200,571 |
| 2006-01-24 | Clingen Brian T (Director) | Sale | 5,000 | 27.52 | 137,600 |
| 2006-01-24 | Clingen Brian T (Director) | Option Exercise | 5,000 | 15.74 | 78,675 |
| 2006-01-04 | Kimmel Roger H (Director) | Sale | 26,128 | 32.00 | 836,096 |
| 2005-11-23 | Kimmel Roger H (Director) | Sale | 43,684 | 30.01 | 1,310,956 |
| 2005-10-12 | Connors James J Ii (10% Owner) | Sale | 51,954,510 | 26.04 | 1,352,895,439 |
| 2005-10-12 | Endo Pharma Llc (10% Owner) | Sale | 21,261,905 | 26.04 | 553,660,006 |
| 2005-10-12 | Kelso Partners V L P (10% Owner) | Sale | 16,398,296 | 26.04 | 427,011,627 |
| 2005-10-12 | Kelso Equity Partners V L P (10% Owner) | Sale | 17,778,107 | 26.04 | 462,941,906 |
| 2005-10-12 | Kelso Investment Assoc V L P (10% Owner) | Sale | 17,778,107 | 26.04 | 462,941,906 |
| 2005-10-12 | Hyatt Michael (Director) | Sale | 255,879 | 26.04 | 6,663,089 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above tables cannot be completely guaranteed as to their accuracy.
For more insider trading information of Endo Pharmaceuticals Holdings Inc (symbol ENDP,
CIK number 1100962) see
the Securities and Exchange Commission (SEC) website.
|
|
